Andrew D. Badley, M.D., an infectious disease specialist, is an experienced physician-scientist and entrepreneur whose active research focuses on novel therapeutic development, especially in the small-molecule, biologic, cellular, and gene therapy space. Dr. Badley has spent almost 30 years at Mayo Clinic as a physician in the Division of Infectious diseases and as a scientist running a lab devoted to virus-host interactions and understanding how the immune system fails to completely clear certain infections, such as HIV, and understanding how this knowledge informs new immuno-oncology approaches. He currently serves as Director of the Human Immunodeficiency Virus Laboratory and is Chair of the Department of Molecular Medicine and the SARS-CoV-2 COVID-19 Task Force.
For more than 20 years, Dr. Badley has received funding from the National Institutes of Health (NIH) to support his research on HIV. In addition to being a frequent public speaker and an adviser to government agencies, he engages in active, hands-on partnering with other scientists and entrepreneurs to help them grow and scale their products. His long-term research goals are to develop novel strategies to cure HIV infection by eradicating HIV reservoirs and to create novel immune-based therapies with applications in both virology and oncology. Dr. Badley received his B.S. and M.D. from Dalhousie University in Halifax, Canada. Dr. Badley holds the HH Sheikh Khalifa Bin Zayed Al Nahyan Professorship of Infectious Diseases honoring Walter R. Wilson, M.D.